High growth medical devices company in Melbourne

Hawthorn VIC

An exceptional opportunity to acquire an established and highly profitable care services business operating within Victoria’s high-care, complex support and community health sector. The business has built a strong reputation for delivering nursing-led, high-intensity and 24/7 care to participants with complex support requirements. It is positioned as a specialist care provider rather than a general support-worker agency, providing an important point of difference in the market. The business is supported by an experienced team of Registered Nurses, Enrolled Nurses and trained Support Workers. Nursing personnel are rostered across most shifts, with clinical support available 24 hours a day, seven days a week. KEY BUSINESS FEATURES: Specialist focus on complex care, high-needs and 24/7 participant support Experienced, nurse-led workforce with strong clinical capability Established participant base, including high-needs clients Services delivered within supported accommodation and private residences Strong compliance systems, procedures and workforce-management processes Growth generated primarily through referrals and professional relationships Government-funded service environment supported by ongoing demand for essential high-care services Contracted aged care-related services delivered through a third-party agency Structured transition and handover available Asking Price: $8,500,000 GROWTH OPPORTUNITIES Potential growth areas include: Additional high-care and complex-support participants Expansion into further supported accommodation and SIL settings Hospital discharge and community-care referral pathways Broader healthcare and allied health partnerships Expansion of in-home and contracted aged care-related services Professional marketing and geographic expansion Additional Support Coordination services, including Levels 2 and 3 This opportunity may suit an established healthcare, nursing, disability support, community care, supported accommodation, home care or aged care organisation seeking a profitable Victorian platform with strong clinical capability and significant growth potential. Due to the highly confidential nature of the sale and the importance of protecting participants, employees and referral relationships, the business name, precise locations and detailed operational information will only be provided to qualified purchasers after completion of a confidentiality agreement.

View full details→

Melbourne VIC

Exciting medical devices company founded by University of Melbourne scientists. Company at forefront of developing a world-first, revolutionary rapid diagnostic devices using proprietary technology. Products range from rapid Covid-19 test, to STD tests and cancer biomarker tests, with wide range of medical applications. Company looking to partner with investors and/or industry professionals to launch its products in the US, EU, Asia and Australia. Company already received two rounds of financing from professional investors and looking to invite new investors to participate in the 3rd round of financing. Company's first human female-use, Chlamydia rapid test has been successfully developed, awaiting clinical trials and regulatory approval as soon as funding is in place. A related product, a Chlamydia rapid test for Koalas, is expected to reach the animal test market by mid-2024, followed by expansions into the much larger livestock rapid test market. Suit high net worth, sophisticated investors including family offices, medical professionals interested in high-growth, high-tech exposure, with massive upside potential.

View full details→

Melbourne VIC

An exceptional opportunity to acquire a cornerstone food manufacturing operation with an immaculate, long-term industry presence and high net profit margins. The enterprise operates a highly scalable model perfectly primed for vertical corporate integration or a national retail rollout. Key Investment Metrics • Revenue: Approximately $15.0 Million per annum with consistent historical growth. • Profitability: Normalized EBITDA of $2.5 Million supported by highly efficient operational cost structures. • Revenue Quality: Deeply diversified commercial customer portfolio with long-term brand equity and high repeat business. • Expansion Potential: Immense latent manufacturing capacity with immediate scope to scale operations into major Tier-1 supermarket chains. Acquisition Terms • Asking Price: $10,800,000 • Target Buyer: Strategic bolt-on acquisition for corporate trade buyers within the manufacturing/FMCG sectors, or Private Equity firms with Exposure to Food Manufacturing looking for a proven platform asset. • Access Requirements: Strictly confidential. Verification of purchaser profile and formal proof of financial capacity are required prior to the release of the Information Memorandum (IM).

View full details→